{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:11:38Z","timestamp":1786792298322,"version":"build-2736575974"},"reference-count":99,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Atrial fibrillation (AF) is frequently associated with cardiometabolic comorbidities, and increasing evidence suggests a close relationship between AF and liver disease, particularly metabolic dysfunction-associated steatotic liver disease (MASLD); however, the clinical patterns, hepatic phenotypes, and clinical implications of this association remain insufficiently characterized. Therefore, the aim of the present study was to characterize hepatic involvement in patients with paroxysmal AF by integrating a structured literature review with original clinical data. Methods: We performed a retrospective analysis of 253 patients admitted with paroxysmal AF between 2015 and 2025. Demographic data and associated diagnoses were collected with a specific focus on hepatic pathology. Patients were stratified according to the presence and type of liver disease, and descriptive statistics, bivariate analyses, and multivariate logistic regression were used to identify associations and independent predictors. Results: Liver disease was identified in 65.2% of patients, most commonly hepatic steatosis (46.2%), followed by liver cirrhosis or advanced liver disease (19.0%). Patients with liver disease had higher prevalences of type 2 diabetes mellitus, dyslipidemia, obesity, and alcohol consumption. Dyslipidemia (OR 4.51) and obesity (OR 2.54) were independent predictors of hepatic steatosis, whereas liver cirrhosis was inversely associated with age and serum lipid levels. Conclusions: Liver pathology is highly prevalent among patients with paroxysmal AF and is closely associated with adverse metabolic and clinical profiles. Recognition of distinct hepatic phenotypes may support improved risk stratification and multidisciplinary management in patients with AF.<\/jats:p>","DOI":"10.3390\/jcm15031156","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:00:47Z","timestamp":1770033647000},"page":"1156","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Paroxysmal Atrial Fibrillation in Liver Diseases: Epidemiology and Possible Pathophysiological Mechanisms"],"prefix":"10.3390","volume":"15","author":[{"given":"Lavinia Alice","family":"B\u0103l\u0103ceanu","sequence":"first","affiliation":[{"name":"Department of Medical Semiology, \u201cSf. Ioan\u201d Clinical Emergency Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Internal Medicine Clinic, \u201cSf. Ioan\u201d Clinical Emergency Hospital, 042122 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9460-2562","authenticated-orcid":false,"given":"Cristiana","family":"Grigore","sequence":"additional","affiliation":[{"name":"Department of Medical Semiology, \u201cSf. Ioan\u201d Clinical Emergency Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Internal Medicine Clinic, \u201cSf. Ioan\u201d Clinical Emergency Hospital, 042122 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6652-4125","authenticated-orcid":false,"given":"Beatrice","family":"B\u0103l\u0103ceanu-Gur\u0103u","sequence":"additional","affiliation":[{"name":"\u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian-Dorin","family":"Gur\u0103u","sequence":"additional","affiliation":[{"name":"Orthopedics and Traumatology Clinic, Clinical Emergency Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Valeria","family":"Grigorescu","sequence":"additional","affiliation":[{"name":"\u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Clinical Department of Gastroenterology, \u201cSf. Ioan\u201d Clinical Emergency Hospital, 042122 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6704-4890","authenticated-orcid":false,"given":"Ion","family":"Dina","sequence":"additional","affiliation":[{"name":"Department of Medical Semiology, \u201cSf. Ioan\u201d Clinical Emergency Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Clinical Department of Gastroenterology, \u201cSf. Ioan\u201d Clinical Emergency Hospital, 042122 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e030438","DOI":"10.1161\/JAHA.123.030438","article-title":"Global Burden of Atrial Fibrillation and Flutter by National Income: Results from the Global Burden of Disease 2019 Database","volume":"12","author":"Ohlrogge","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","unstructured":"Olshansky, B., and Arora, R.K. (2025, July 08). Mechanisms of Atrial Fibrillation. Available online: https:\/\/www.uptodate.com\/contents\/mechanisms-of-atrial-fibrillation."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/europace\/eux163","article-title":"European Heart Rhythm Association (EHRA)\/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)","volume":"19","author":"Gorenek","year":"2017","journal-title":"Europace"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Pierucci, N., Mariani, M.V., Iannetti, G., Maffei, L., Coluccio, A., Laviola, D., Palombi, M., Trivigno, S., Spadafora, L., and Chourda, E. (2025). Atrial cardiomyopathy: New pathophysiological and clinical aspects. Minerva Cardiol. Angiol., in press.","DOI":"10.23736\/S2724-5683.25.06725-0"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"106147","DOI":"10.4330\/wjc.v17.i6.106147","article-title":"Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis","volume":"17","author":"Bharaj","year":"2025","journal-title":"World J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.amjcard.2017.05.027","article-title":"Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients with Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation (CONNECT AF)","volume":"120","author":"Silberberg","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"155958","DOI":"10.1016\/j.metabol.2024.155958","article-title":"Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: A systematic analysis from the global burden of disease study 2019","volume":"158","author":"Danpanichkul","year":"2024","journal-title":"Metabolism"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12967-021-03210-9","article-title":"Increased burden of cardiovascular disease in people with liver disease: Unequal geographical variations, risk factors and excess years of life lost","volume":"20","author":"Chang","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ramadan, M.S., Russo, V., Nigro, G., Durante-Mangoni, E., and Zampino, R. (2021). Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective. J. Clin. Med., 10.","DOI":"10.3390\/jcm10081569"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Zhou, B.G., Ju, S.Y., Mei, Y.Z., Jiang, X., Wang, M., Zheng, A.-J., and Ding, Y.-B. (2023). A systematic review and meta-analysis of cohort studies on the potential association between NAFLD\/MAFLD and risk of incident atrial fibrillation. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1160532"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020","volume":"56","author":"Tokushige","year":"2021","journal-title":"J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"393","author":"Targher","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People with Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J. Clin. Epidemiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11430","DOI":"10.1038\/s41598-025-94783-8","article-title":"Impact of steatotic liver disease categories on atrial fibrillation in type 2 diabetes: A nationwide study","volume":"15","author":"Cho","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3000605211047074","DOI":"10.1177\/03000605211047074","article-title":"Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: A systematic review and meta-analysis","volume":"49","author":"Gong","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/liv.14461","article-title":"Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation","volume":"40","author":"Cai","year":"2020","journal-title":"Liver Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/liv.14236","article-title":"Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults","volume":"40","author":"Roh","year":"2020","journal-title":"Liver Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.clinre.2017.08.001","article-title":"The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis","volume":"41","author":"Wijarnpreecha","year":"2017","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/07853890.2018.1492147","article-title":"The association of non-alcoholic fatty liver disease and atrial fibrillation: A review","volume":"50","author":"Hukkanen","year":"2018","journal-title":"Ann. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e005227","DOI":"10.1161\/JAHA.116.005227","article-title":"Relations of Liver Fat with Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study","volume":"6","author":"Long","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Argano, C. (2023). Editorial: Interactions between NAFLD and cardiac conduction, structure and function: Recent advances and treatments. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1334227"},{"key":"ref_33","first-page":"e1142","article-title":"Link Between Non-Alcoholic Fatty Liver Disease and Atrial Fibrillation: A Systematic Review and Meta-Analysis","volume":"9","author":"Minhas","year":"2017","journal-title":"Cureus"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","article-title":"Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"29","author":"Alon","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101643","DOI":"10.1016\/j.cpcardiol.2023.101643","article-title":"Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis","volume":"48","author":"Bisaccia","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tana, C., Ballestri, S., Ricci, F., Di Vincenzo, A., Ticinesi, A., Gallina, S., Giamberardino, M.A., Cipollone, F., Sutton, R., and Vettor, R. (2019). Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16173104"},{"key":"ref_37","first-page":"e1165","article-title":"Non-Alcoholic Fatty Liver Disease Association with Cardiac Arrhythmias","volume":"9","author":"Mangi","year":"2017","journal-title":"Cureus"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"60673","DOI":"10.18632\/oncotarget.19522","article-title":"Linking atrial fibrillation with non-alcoholic fatty liver disease: Potential common therapeutic targets","volume":"8","author":"Ding","year":"2017","journal-title":"Oncotarget"},{"key":"ref_39","first-page":"250","article-title":"Nonalcoholic fatty liver disease as a predictor of atrial fibrillation: A systematic review and meta-analysis","volume":"13","author":"Zhou","year":"2017","journal-title":"Postepy Kardiol. Interwencyjnej"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3349\/ymj.2020.61.10.860","article-title":"Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease","volume":"61","author":"Kang","year":"2020","journal-title":"Yonsei Med. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1038\/s41598-020-61750-4","article-title":"The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index","volume":"10","author":"Park","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12933-024-02408-7","article-title":"Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups","volume":"23","author":"Cho","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Choi, J., Lee, S.R., Choi, E.K., Ahn, H.-J., Kwon, S., Park, S.-H., Lee, H., Chung, J., Han, M., and Lee, S.-W. (2022). Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.832023"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jacc.2021.11.007","article-title":"Risk of Heart Failure in Patients with Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week","volume":"79","author":"Mantovani","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCRESAHA.121.319059","article-title":"Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia","volume":"128","author":"Chen","year":"2021","journal-title":"Circ. Res."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Wang, L., Zhang, Y., Yu, B., Zhao, J., Zhang, W., Fan, H., Ren, Z., and Liang, B. (2023). The monocyte-to-high-density lipoprotein ratio is associated with the occurrence of atrial fibrillation among NAFLD patients: A propensity-matched analysis. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1127425"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Liu, G., Zhang, Q., Zhou, M., Li, B., Zhao, J., Bai, R., Song, X., Qin, W., and Zhang, Y. (2024). Correlation between serum uric acid to high-density lipoprotein cholesterol ratio and atrial fibrillation in patients with NAFLD. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0305952"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102580","DOI":"10.1016\/j.cpcardiol.2024.102580","article-title":"Electrocardiographic abnormalities in patients with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis","volume":"49","author":"Dimala","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Decoin, R., Butruille, L., Defrancq, T., Robert, J., Destrait, N., Coisne, A., Aghezzaf, S., Woitrain, E., Gouda, Z., and Schino, S. (2022). High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.957245"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.acvd.2024.02.001","article-title":"Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC). Left atrial cardiomyopathy: Pathophysiological insights, assessment methods and clinical implications","volume":"117","author":"Ninni","year":"2024","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacep.2020.05.023","article-title":"Impact of Nonalcoholic Fatty Liver Disease on Arrhythmia Recurrence Following Atrial Fibrillation Ablation","volume":"6","author":"Donnellan","year":"2020","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"AlTurki, A., and Essebag, V. (2025). Atrial Fibrillation Ablation: Impact on Burden and Cardiovascular Outcomes. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082648"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Matteucci, A., Russo, M., Galeazzi, M., Pandozi, C., Bonanni, M., Mariani, M.V., Pierucci, N., La Fazia, V.M., Di Fusco, S.A., and Nardi, F. (2025). Impact of Ablation Energy Sources on Perceived Quality of Life and Symptom in Atrial Fibrillation Patients: A Comparative Study. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082741"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e16128","DOI":"10.1111\/liv.16218","article-title":"MASLD Is Associated with an Increased Long-Term Risk of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis","volume":"45","author":"Mantovani","year":"2025","journal-title":"Liver Int."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Huang, J.K., and Lee, H.C. (2022). Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL). Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23084300"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"102626","DOI":"10.1016\/j.cpcardiol.2024.102626","article-title":"A review regarding the article \u2018Electrocardiographic abnormalities in patients with metabolic dysfunction-associated Steatotic liver disease: A systematic review and meta-analysis\u2019","volume":"49","author":"Li","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12933-023-02070-5","article-title":"Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: A nationwide histology cohort study","volume":"22","author":"Simon","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Cheung, J., Cheung, B.M., Yiu, K.H., Tse, H.F., and Chan, Y.H. (2025). Role of metabolic dysfunction-associated fatty liver disease in atrial fibrillation and heart failure: Molecular and clinical aspects. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1573841"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/HEP.0000000000000735","article-title":"Metabolic dysfunction-associated steatotic liver disease and the heart","volume":"82","author":"Driessen","year":"2023","journal-title":"Hepatology"},{"key":"ref_60","first-page":"e60968","article-title":"Mortality, Hepatic Decompensation, and Cardiovascular- and Renal-Related Outcomes in Lean Versus Non-lean Patients Hospitalized with Metabolic Dysfunction-Associated Steatohepatitis (MASH)","volume":"16","author":"Ezeani","year":"2024","journal-title":"Cureus"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"9335","DOI":"10.1038\/s41467-024-53568-9","article-title":"Sequence variants associated with BMI affect disease risk through BMI itself","volume":"15","author":"Einarsson","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1038\/s41598-021-83367-x","article-title":"Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: A nationwide population-based study","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jhep.2023.05.046","article-title":"Liver disease is a significant risk factor for cardiovascular outcomes\u2014A UK Biobank study","volume":"79","author":"Banerjee","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacep.2020.06.029","article-title":"Risk Factor Modification for Atrial Fibrillation: An Ounce of Prevention","volume":"6","author":"Estes","year":"2020","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/europace\/eux177","article-title":"Screening for atrial fibrillation: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci\u00f3n Card\u00edaca y Electrofisiolog\u00eda (SOLAECE)","volume":"19","author":"Mairesse","year":"2017","journal-title":"Europace"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement from the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e008703","DOI":"10.1161\/JAHA.118.008703","article-title":"Liver Disease as a Predictor of New-Onset Atrial Fibrillation","volume":"7","author":"Huang","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4330\/wjc.v12.i7.342","article-title":"Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis","volume":"12","author":"Darrat","year":"2020","journal-title":"World J. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"950","DOI":"10.33963\/v.kp.97812","article-title":"Atrial fibrillation in patients with liver disease: Recent advances","volume":"81","author":"Godtfredsen","year":"2023","journal-title":"Kardiol. Pol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/liv.13459","article-title":"Cirrhosis is a risk factor for atrial fibrillation: A nationwide, population-based study","volume":"37","author":"Lee","year":"2017","journal-title":"Liver Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/MEG.0000000000001315","article-title":"Epidemiology of atrial fibrillation in patients with cirrhosis and clinical significance: A meta-analysis","volume":"31","author":"Chokesuwattanaskul","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/liv.14291","article-title":"Atrial fibrillation in hospitalized patients with end-stage liver disease: Temporal trends in prevalence and outcomes","volume":"40","author":"Han","year":"2020","journal-title":"Liver Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.hrtlng.2019.07.002","article-title":"Predictors, burden and impact of cardiac arrhythmias among patients hospitalized with end-stage liver disease","volume":"49","author":"Adejumo","year":"2020","journal-title":"Heart Lung"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4254\/wjh.v7.i4.662","article-title":"Arrhythmia risk in liver cirrhosis","volume":"7","author":"Mozos","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Mann, J.P., Carter, P., Armstrong, M.J., Abdelaziz, H.K., Uppal, H., Patel, B., Chandran, S., More, R., Newsome, P.N., and Potluri, R. (2020). Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0241357"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.amjcard.2019.11.006","article-title":"Effect of Serum Albumin Levels in Patients with Heart Failure with Preserved Ejection Fraction (from the TOPCAT Trial)","volume":"125","author":"Prenner","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Lu, X., Wang, Z., Yang, L., Yang, C., and Song, M. (2021). Risk Factors of Atrial Arrhythmia in Patients with Liver Cirrhosis: A Retrospective Study. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.704073"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.21037\/atm-21-3111","article-title":"Atrial fibrillation increases inpatient and 4-year all-cause mortality in critically ill patients with liver cirrhosis","volume":"9","author":"Luo","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_79","first-page":"e38536","article-title":"The Liver-Heart Connection: A Literature Review of Liver Disease as a Risk Factor for Atrial Fibrillation","volume":"15","author":"Obi","year":"2023","journal-title":"Cureus"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"563","DOI":"10.33963\/KP.a2023.0115","article-title":"Gut dysbiosis-derived low-grade endotoxemia: A common basis for liver and cardiovascular disease","volume":"81","author":"Violi","year":"2023","journal-title":"Kardiol. Pol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3748\/wjg.v30.i2.128","article-title":"Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?","volume":"30","author":"Wu","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jhep.2022.05.030","article-title":"Liver stiffness not fatty liver disease is associated with atrial fibrillation: The Rotterdam study","volume":"77","author":"Lu","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10654-023-01094-1","article-title":"The Rotterdam Study. Design update and major findings between 2020 and 2024","volume":"39","author":"Ikram","year":"2024","journal-title":"Eur. J. Epidemiol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Saito, Y., Okumura, Y., Nagashima, K., Fukamachi, D., Yokoyama, K., Matsumoto, N., Tachibana, E., Kuronuma, K., Oiwa, K., and Matsumoto, M. (2020). Impact of the Fibrosis-4 Index on Risk Stratification of Cardiovascular Events and Mortality in Patients with Atrial Fibrillation: Findings from a Japanese Multicenter Registry. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020584"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"101171","DOI":"10.1016\/j.jhepr.2024.101171","article-title":"Inflammation in liver fibrosis and atrial fibrillation: A prospective population-based proteomic study","volume":"6","author":"Boeckmans","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Chu, Y., Yu, F., Wu, Y., Yang, J., Shi, J., Ye, T., Han, D., and Wang, X. (2022). Identification of genes and key pathways underlying the pathophysiological association between nonalcoholic fatty liver disease and atrial fibrillation. BMC Med. Genom., 15.","DOI":"10.1186\/s12920-022-01300-1"},{"key":"ref_87","first-page":"540","article-title":"Clinical Genetic Testing for Atrial Fibrillation: Are We There Yet?","volume":"40","author":"Roberts","year":"2024","journal-title":"Can. J. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1756284819832237","DOI":"10.1177\/1756284819832237","article-title":"Gastrointestinal and liver diseases and atrial fibrillation: A review of the literature","volume":"12","author":"Long","year":"2019","journal-title":"Therap. Adv. Gastroenterol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e29929","DOI":"10.1016\/j.heliyon.2024.e29929","article-title":"Global association of incidence between atrial fibrillation and the major gastrointestinal cancers: An analysis based on the 2019 Global burden of disease study","volume":"10","author":"Huang","year":"2024","journal-title":"Heliyon"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e236910","DOI":"10.1136\/bcr-2020-236910","article-title":"Rare and unusual presentation of gastrocardiac syndrome","volume":"13","author":"Mehta","year":"2020","journal-title":"BMJ Case Rep."},{"key":"ref_91","first-page":"e10387","article-title":"Gastroesophageal Reflux and Its Association with Atrial Fibrillation: A Traditional Review","volume":"12","author":"Mohamed","year":"2020","journal-title":"Cureus"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"102952","DOI":"10.1016\/j.cpcardiol.2024.102952","article-title":"Integrative approaches to atrial fibrillation prevention and management: Leveraging gut health for improved cardiovascular outcomes in the aging population","volume":"50","author":"Williams","year":"2025","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(19)31721-0","article-title":"An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: A retrospective analysis of outcome prediction","volume":"394","author":"Attia","year":"2019","journal-title":"Lancet"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41591-018-0240-2","article-title":"Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram","volume":"25","author":"Attia","year":"2019","journal-title":"Nat. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.jacc.2018.03.521","article-title":"Artificial Intelligence in Cardiology","volume":"71","author":"Johnson","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41591-018-0268-3","article-title":"Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network","volume":"25","author":"Hannun","year":"2019","journal-title":"Nat. Med."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Karakasis, P., Theofilis, P., Sagris, M., Pamporis, K., Stachteas, P., Sidiropoulos, G., Vlachakis, P.K., Patoulias, D., Antoniadis, A.P., and Fragakis, N. (2025). Artificial Intelligence in Atrial Fibrillation: From Early Detection to Precision Therapy. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082627"},{"key":"ref_98","first-page":"75","article-title":"Results of prevalence study regarding comorbidities for various patients","volume":"61","author":"Capisizu","year":"2013","journal-title":"Rom. Stat. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"215","DOI":"10.15403\/jgld.2014.1121.232.so1","article-title":"Partial splenic embolization for hypersplenism in cirrhotic patients. A case series","volume":"23","author":"Omer","year":"2014","journal-title":"J. Gastrointestin Liver Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/3\/1156\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:21:18Z","timestamp":1770034878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/3\/1156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":99,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["jcm15031156"],"URL":"https:\/\/doi.org\/10.3390\/jcm15031156","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}